VEGF-induced angiogenesis drives collateral circulation in portal hypertension

Journal of Hepatology

Volumn 43, Issue 1, 2005, Pages 6-8

  Moreau, Richard ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANGIOGENIN; ANGIOPOIETIN; BASIC FIBROBLAST GROWTH FACTOR; INTERLEUKIN 8; ISOPROTEIN; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; BLOOD VESSEL PERMEABILITY; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COLLATERAL CIRCULATION; DRUG EFFECT; DRUG MECHANISM; EDITORIAL; ENDOTHELIUM CELL; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HYPOXIA; NONHUMAN; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

ANIMALS; COLLATERAL CIRCULATION; HUMANS; HYPERTENSION, PORTAL; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 20444420475     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.04.002     Document Type: Editorial

References (16)

1. D. Lebrec, and R. Moreau Pathophysiology of portal hypertension Hepato-Gastroenterol 46 1999 1426 1428
2. M. Fernandez, F. Vizzutti, J.C. Garcia-pagan, J. Rodés, and J. Bosch Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice Gastroenterology 126 2004 886 894
3. M. Fernandez, M. Mejias, B. Angermayr, J.C. Garcia-Pagan, J. Rodés, and J. Bosch Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats J Hepatol 43 2005 98 103
4. W. Risau Mechanisms of angiogenesis Nature 386 1997 671 674
5. R.K. Jain Molecular regulation of vessel maturation Nat Med 9 2003 685 693
6. P. Carmeliet Angiogenesis in health and disease Nat Med 9 2003 653 660
7. N. Ferrara, H.P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat Med 9 2003 669 676
8. P. Carmeliet Mechanisms of angiogenesis and arteriogenesis Nat Med 6 2000 389 395
9. I. Stalmans, Y.S. Ng, R. Rohan, M. Fruttiger, A. Bouche, and A. Yuce Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms J Clin Invest 109 2002 327 336
10. P. Carmeliet, Y.S. Ng, D. Nuyens, G. Theilmeier, K. Brusselmans, and I. Cornelissen Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 Nat Med 5 1999 495 502
11. C. Ruhrberg, H. Gerhardt, M. Golding, R. Watson, S. Ioannidou, and H. Fujisawa Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis Genes Dev 16 2002 2684 2698
12. H. Gerhardt, M. Golding, M. Fruttiger, C. Ruhrberg, A. Lundkvist, and A. Abramsson VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia J Cell Biol 161 2003 1163 1177
13. N. Jones, K. Iljin, D.J. Dumont, and K. Alitalo TIE receptors: new modulators of angiogenic and lymphangiogenic responses Nat Rev Mol Cell Biol 2 2001 257 267
14. P. Carmeliet, L. Moons, A. Luttun, V. Vincenti, V. Compernolle, and M. De Mol Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions Nat Med 7 2001 575 583
15. M. Autiero, J. Waltenberger, D. Communi, A. Kranz, L. Moons, and D. Lambrechts Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 Nat Med 9 2003 936 943
16. K.A. Tazi, E. Barrière, R. Moreau, J. Heller, P. Sogni, and D. Pateron Role of shear stress in aortic eNOS up-regulation in rats with biliary cirrhosis Gastroenterology 122 2002 1869 1877